These findings highlight CDK12 as a pro-survival transcriptional kinase that integrates oncogenic signaling and DNA-repair regulation in HCC, providing a rationale for dual targeting of CDK12 and receptor-tyrosine-kinase pathways. This evidence concerns the gene CDK12 and hepatocellular carcinoma.